Peptide questions · Urolithin A

Urolithin A side effects: what studies and users report

Reviewed Evidence: EmergingPublished by PepVault

The library lists one common side effect for Urolithin A, usually none above placebo in the trials, and a safety note; the library’s evidence on it includes controlled trials in people.

Its safety note opens: A dietary supplement; most trials tested one company's product.

What is commonly reported with Urolithin A

  • Usually none above placebo in the trials

Common here means the library lists it among the effects people most often report; the list doesn’t say how often each one happens.

Each effect, and the other longevity compounds the library lists it for
EffectAlso listed for (of 37)
Usually none above placebo in the trials3: NAC, Nicotinamide Riboside, Spermidine
A smiling man in a grey t-shirt in his living room, holding his phone

PepVault for iPhone

Track Urolithin A in PepVault

Log each dose and any side effect beside it, so you can see what changed and when.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Which Urolithin A side effects the longevity group shares

Across the 38 longevity compounds in the library, the effects listed most often are usually none above placebo in the trials (4 of 38), acne (2 of 38), not well characterised in people yet (2 of 38) and rare liver injury (supplement-associated) (2 of 38). Every effect on Urolithin A’s list also appears for at least one other longevity compound, so nothing on it is Urolithin A’s own.

What the Urolithin A safety notes say

The library’s safety note

A dietary supplement; most trials tested one company's product. Safety was the main outcome of the first human trial and was favourable, and in a 4-month trial in adults aged 65–90, adverse events did not differ from placebo. No upper level has been set. Discuss with your clinician.

The library’s interaction note

No drug interactions were reported in the urolithin A trials read. Discuss any prescription medications with your clinician.

These are reference notes from published research and reported use, not advice for a person: discuss your own situation with your clinician.

Where the Urolithin A reports come from

The library rates the evidence on Urolithin A as emerging: mostly preclinical, with limited human data.

Of the library’s 5 research notes on Urolithin A, 4 rest on randomized trials and 1 on community reports.

So Urolithin A has controlled trials in people to set its listed effects against.

Questions people ask

What are the side effects of Urolithin A?

The library lists one common side effect for Urolithin A, usually none above placebo in the trials, and a safety note; the library’s evidence on it includes controlled trials in people.

Do Urolithin A’s side effects come from human studies?

The library rates the evidence on Urolithin A as emerging, and the library’s evidence on it includes controlled trials in people.

Which Urolithin A side effects are its own?

None: each effect the library lists for Urolithin A is listed for at least one other longevity compound too.

Does Urolithin A interact with other medicines?

The library’s interaction note on Urolithin A begins: No drug interactions were reported in the urolithin A trials read.

More on Urolithin A

Track it in the app

PepVault for iPhone

Track Urolithin A in PepVault

Log each dose and any side effect beside it, so you can see what changed and when.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo